已發(fā)表論文：（*為通訊作者，#為共同一作） (1) Zhenli Li (#), Geng Chen(#), Zhixiong Cai, Xiuqing Dong, Lei He, Liman Qiu, Yongyi Zeng, Xiaolong Liu (*), Jingfeng Liu(*), Profiling of Hepatocellular Carcinoma Neoantigens Reveals Immune icroenvironment and Clonal Evolution Related Patterns, Chin J Cancer Res. 2021 Jun 30;33(3):364-378. (2) Hengkai Chen(#), Zhenli Li(#), Liman Qiu, Xiuqing Dong, Geng Chen, Yingjun Shi, Linsheng Cai, Wenhan Liu, Honghao Ye, Yang Zhou, Jiahe Ouyang, Zhixiong Cai(*), Xiaolong Liu(*)，Personalized neoantigen vaccine combined with PD-1 blockade increases CD8+ tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models，J Immunother Cancer. 2022 Sep;10(9):e004389. (3) Zhixiong Cai(#), Xiaoping Su(#), Liman Qiu(#), Zhenli Li(#), Xiaolou Li, Xiuqing Dong, Fuqun Wei, Yang Zhou, Liuping Luo, Geng Chen, Hengkai Chen, Yingchao Wang, Yongyi Zeng(*), Xiaolong Liu(*), Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion, Mol Cancer. 2021 Dec 13;20(1):164. (4) Yongyi Zeng(#),Wei Zhang(#), Zhenli Li(#), Youshi Zheng(#), Yingchao Wang, Geng Chen, Liman Qiu, Kun Ke, Xiaoping Su, Zhixiong Cai, Jingfeng Liu(*), and Xiaolong Liu(*)，Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report，J Immunother Cancer. 2020; 8(1): e000217. (5) Liman Qiu(#), Yanbing Huang(#), Zhenli Li(#), Xiuqing Dong, Geng Chen, Haipo Xu,Yongyi Zeng Zhixiong Cai(*), Xiaolong Liu(*),J ingfeng Liu(*)，Circular RNA profiling identifies circADAMTS13 as a miR‐484 sponge which suppresses cell proliferation in hepatocellular carcinoma，Mol Oncol. 2019 Feb;13(2):441-455. (6) Zhenli Li(#), Geng Chen(#), Zhixiong Cai(#), Xiuqing Dong(#), Liman Qiu, Haipo Xu, Yongyi Zeng, Xiaolong Liu(*), Jingfeng Liu(*), Genomic and transcriptional Profiling of tumor infiltrated CD8+ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma, Oncoimmunology. 2018 Nov 10;8(2):e1538436. (7) Kun Ke(#), Geng Chen(#), Zhixiong Cai, Yanbing Huang, Bixing Zhao, Yingchao Wang, Naishun Liao,Xiaolong Liu, Zhenli Li(*), Jingfeng Liu(*)，Evaluation and Prediction of Hepatocellular Carcinoma Prognosis Based on Molecular Classification, Cancer Manag Res. 2018 Nov 5;10:5291-5302. (8) Dandan Zhang(*#), Zhenli Li(#), Xiaohong Xu, Dan Zhou, Shunli Tang, Xiaoyang Yin, Fangying Xu, Hui Li, Yuan Zhou, Tao Zhu, Hong Deng, Shuai Zhang, Qiong Huang, Jing Wang, Wei Yin6, Yimin Zhu, Maode Lai(*),Germline deletions at SLC18A1 increased the risk of colorectal cancers, Carcinogenesis. 2017 Oct 26;38(11):1057-1062 2017. (9) Zhenli Li, Dan Yu, Meifu Gan, Qiaonan Shan, Xiaoyang Yin, Shunli Tang, Shuai Zhang, Yongyong Shi, Yimin Zhu, Maode Lai(*), Dandan Zhang(*), A genome-wide assessment of rare copy number variants in colorectal cancer, Oncotarget. 2015 Sep 22; 6(28):26411-23. (10) Dandan Zhang(#), Zhenli Li(#), Hao Wang, Min Yang, Li Liang, Junfen Fu, Chunling Wang, Jie Ling, Yan Zhang, Shuai Zhang, Yuyang Xu, Yimin Zhu(*), Maode Lai(*), Interactions between Obesity-Related Copy Number Variants and Dietary Behaviors in Childhood Obesity, Nutrients. 2015 Apr 22;7(4):3054-66.
授權(quán)發(fā)明專利： (1) 發(fā)明人：劉小龍, 劉景豐, 李振麗, 柯坤, 蔡志雄, 陳耕. 一種用于肝癌患者預(yù)后風(fēng)險(xiǎn)評(píng)估的基因檢測(cè)試劑盒及應(yīng)用. 授權(quán)號(hào)：CN201810448563.5, 授權(quán)日期：20180511, 專利權(quán)人: 福建醫(yī)科大學(xué)孟超肝膽醫(yī)院（福州市傳染病醫(yī)院）. 授權(quán)計(jì)算機(jī)軟件著作權(quán): (2) 著作權(quán)人：劉小龍, 李振麗, 蔡志雄, 陳耕，曾永毅. NeoTect腫瘤新生抗原預(yù)測(cè)軟件V1.0. 登記號(hào)：2022SR1376044， 授權(quán)日期：20220927.
|
